SCHEMBL3801917

SCHEMBL3801917

COC(=O)C(Cc1ccc(O)cc1)(OC)C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.47
BLM P54132 1/20 0.46
PTPRB P23467 7/20 0.45
ESR2 Q92731 3/20 0.43
PTPN1 P18031 2/20 0.42
PTPN2 P17706 1/20 0.42
PTPRA P18433 1/20 0.42
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA12 O43570 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
MIF P14174 1/20 0.40
ACP1 P24666 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
KDM4E B2RXH2 1/20 0.40
F13A1 P00488 1/20 0.40
TYR P14679 1/20 0.40
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28420568 0.84 PTPRB (0.54) PTPRBPTPN1PTPN2PTPRAACP1
SCHEMBL3665931 0.80 ESR1 (0.53) ESR1BLMPTPRBESR2PTPN1
SCHEMBL3801919 0.78 BLM (0.46) ESR1BLMPTPRBESR2PTPN1
SCHEMBL540243 0.77 BLM (0.67) ESR1BLMPTPRBESR2PTPN1
SCHEMBL503525 0.77 BLM (0.67) ESR1BLMPTPRBESR2PTPN1
SCHEMBL503526 0.77 BLM (0.67) ESR1BLMPTPRBESR2PTPN1
SCHEMBL9285117 0.77 BLM (0.53) ESR1BLMPTPRBESR2PTPN1
Hydrochloric Acid SCHEMBL540244 0.76 BLM (0.65) ESR1BLMPTPRBESR2PTPN1
Hydrochloric Acid SCHEMBL1322060 0.76 BLM (0.65) ESR1BLMPTPRBESR2PTPN1
SCHEMBL6514361 0.76 ESR1 (0.48) ESR1BLMPTPRBESR2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2064545-B1 METHOD FOR IDENTIFYING COMPOUNDS THAT ACT AS INSULIN-SENSITIZERS PIRAMAL LIFE SCIENCES LTD (IN) 2012-07-04 EP disclosed
EP-2256496-A2 Method for identifying compounds that act as insulin-sensitizers Piramal Life Sciences Limited (IN) 2010-12-01 EP disclosed
US-20090318465-A1 METHOD FOR IDENTIFYING COMPOUNDS THAT ACT AS INSULIN-SENSITIZERS Piramal Enterprises Limited (IN) 2009-12-24 US disclosed
EP-2064545-A2 METHOD FOR IDENTIFYING COMPOUNDS THAT ACT AS INSULIN-SENSITIZERS Piramal Life Sciences Limited (IN) 2009-06-03 EP disclosed
WO-2008035309-A2 METHOD FOR IDENTIFYING COMPOUNDS THAT ACT AS INSULIN-SENSITIZERS PIRAMAL LIFE SCIENCES LIMITED (IN) 2008-03-27 WO disclosed
EP-1687252-A2 PROCESS FOR THE PRODUCTION OF ALPHA-ALKOXY/HYDROXY-BETA-(P-HYDROXYPHENYL) PROPIONIC ACID DERIVATIVES Degussa AG (DE) 2006-08-09 EP disclosed
WO-2005026096-A2 PROCESS FOR THE PRODUCTION OF ALPHA-ALKOXY/HYDROXY-BETA-(P-HYDROXYPHENYL) PROPIONIC ACID DERIVATIVES DEGUSSA AG (DE) 2005-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318465-A1 METHOD FOR IDENTIFYING COMPOUNDS THAT ACT AS INSULIN-SENSITIZERS GPR119, SLC2A4, INSR ESR1 819/4885BLM 4214/4885PTPRB 1002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.